The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Clinical trial NCT03239119 · UNKNOWN
Trial details
- NCT number
- NCT03239119
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2018-12-30
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.